Genotech (XKRX:066830) ROCE % : -2.00% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Genotech ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Genotech's annualized ROCE % for the quarter that ended in Dec. 2023 was -2.00%.

Genotech ROCE % Historical Data

The historical data trend for Genotech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genotech ROCE % Chart

Genotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

6.42

66.35

34.85

15.51

-2.00

Genotech Semi-Annual Data
	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
ROCE %	Get a 7-Day Free Trial				6.42	66.35	34.85	15.51	-2.00

Genotech ROCE % Calculation

Genotech's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-240.52	/	( ( (13232.762 - 1079.476)	+	(12233.383 - 321.521) )	/ 2 )
	=	-240.52	/	( (12153.286	+	11911.862)	/ 2 )
	=	-240.52	/	12032.574
	=	-2.00 %

Genotech's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Dec. 2022 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Dec. 2022 )		(Q: Dec. 2023 )
	=	-240.52	/	( ( (13232.762 - 1079.476)	+	(12233.383 - 321.521) )	/ 2 )
	=	-240.52	/	( ( 12153.286	+	11911.862 )	/ 2 )
	=	-240.52	/	12032.574
	=	-2.00 %

(1) Note: The EBIT data used here is one times the annual (Dec. 2023) EBIT data.

Genotech (XKRX:066830) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Genotech ROCE % Related Terms

Thank you for viewing the detailed overview of Genotech's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genotech (XKRX:066830) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genotech Corp (XKRX:066830) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

26-69, Gajeongbuk-ro, Yuseong-gu, Daejeon, KOR, 305-343

Website

http://www.genotech.net

Genotech Corp is engaged in manufacturing basic pharmaceutical substances and biological agents.

Genotech (XKRX:066830) Headlines

No Headlines